F
FLNA
Filana Therapeutics
0.8201
-0.0082-0.99%Pre Market: 0.8108 -0.0093 -1.13%05:45 09/08 EDT
OPEN/PREV CLOSE0.7889/0.7972
TODAY RANGE0.7581-0.8121
VOL2.68K
MARKET CAP39.08M
52 WEEK RANGE0.7500-4.980
AVG VOL (3M)318.67K
% TURNOVER0.56%
TURNOVER0
P/E (TTM)-0.9241
% RANGE6.47%
EPS(TTM)-0.8753
P/E(FORWARD)-0.9038
P/B0.6143
BVPS1.317
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP38.28M
SHARES OUTSTANDING48.31M
NEXT EARNINGS11/10-11/16
FREE FLOAT47.32M
LOT SIZE1
EX-DATE12/21/2023
News
Press Releases
Financial Reports
Profile
Seeking Alpha·07/29 12:05
Cassava Sciences GAAP EPS of -$0.18 beats by $0.05
Benzinga·07/29 12:04
Filana Therapeutics Q2 EPS $(0.18) Beats $(0.23) Estimate
Dow Jones·07/29 12:01
*Filana Therapeutics 2Q Research and Development Expenses $3.3M >FLNA
Dow Jones·07/29 12:00
Press Release: Filana Therapeutics Reports Q2 -2-
TipRanks·06/15 10:55
Filana Therapeutics Shareholders Back Board, Compensation Plans
TipRanks·05/30 09:01
BridgeBio, Dave, Marvell, Filana, GE Trending With Analysts
Dow Jones·05/26 20:02
Filana Therapeutics Price Target Announced at $5.00/Share by Maxim Group
Benzinga·05/26 19:53
Maxim Group Reinstates Buy on Filana Therapeutics, Announces $5 Price Target
TipRanks·05/26 13:58
Filana Therapeutics resumed with Buy at Maxim on rebranding, strategic pivot
TipRanks·05/26 12:40
Filana Therapeutics resumed with a Buy at Maxim
Seeking Alpha·05/07 12:03
Cassava Sciences GAAP EPS of -$0.21 beats by $0.02
Dow Jones·05/07 12:01
*Filana Therapeutics 1Q Loss/Shr 21c >FLNA
Same Industry
Name/Symbol
Change%
Price